Our in-vitro diagnostic test kit based on rapid Polymerase Chain Reaction (PCR) amplification technology. This kit can reliably detect and distinguish the mutants from UK (20I/501Y.V1, B.1.1.7 – VOC-202012/01) as well as the South African mutation (B.1.351 lineage). The test kit is aimed to improve the public health situation by rapidly enabling the detection of variants of concern.
The kit is designed for quantitative detection of variants of interest of the SARS-CoV-2 Viral RNA in direct nasal, nasopharyngeal or throat swabs* and it works in conjuction with our peakPCR devices
* For Research Applications Only
The test kits are sold with all the necessary reagents pre-loaded in the reaction wells. The use of the test kits is therefore extremely simple:
Our test kits have undergone a preliminary validation at the Swiss Tropical and Public Health Institute (Swiss TPH).
Would you like to know more about our performance data and the validation of our kits? Please contact us!
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.